Transcode Therapeutics reported total assets of $151.01M and total liabilities of $12.65M for the quarter ended Jun 2026. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.04M | 0.06M | 0.09M | 0.11M | 0.14M | 0.17M | 0.20M | 0.23M | 0.26M | 0.30M | 0.33M | 0.34M | 0.31M | 0.32M | 0.34M | 0.34M | 0.39M | 0.41M | 0.44M | ||||||
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 22.50M | 20.83M | 16.90M | 13.44M | 8.80M | 4.97M | 1.62M | 3.60M | 7.50M | 2.77M | 4.91M | 3.40M | 1.90M | 5.81M | 11.60M | 7.40M | 2.84M | 17.81M | 12.84M | 8.40M | |||||
| Receivables - OtherOther Receivables | 0.49M | 0.36M | 0.01M | 0.32M | 0.18M | 0.20M | 0.95M | 638.00 | 638.00 | ||||||||||||||||
| Prepaid Assets | 2.70M | 1.91M | 1.78M | 0.48M | 2.29M | 2.05M | 2.72M | 1.32M | 1.92M | 1.69M | 1.80M | 1.03M | 1.72M | 1.28M | 1.15M | 0.69M | 1.72M | 0.92M | 1.62M | 2.26M | |||||
| Current Assets | 25.20M | 22.73M | 18.63M | 13.92M | 11.57M | 7.38M | 4.35M | 4.89M | 9.37M | 4.46M | 6.71M | 4.39M | 3.61M | 7.09M | 13.04M | 8.24M | 4.75M | 21.98M | 16.75M | 10.64M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.16M | 0.21M | 0.22M | 0.23M | 0.21M | 0.21M | 0.19M | 0.18M | 0.15M | 0.12M | 0.09M | 0.06M | 0.06M | 0.05M | 0.04M | 0.02M | 0.02M | 0.37M | 0.35M | 0.32M | |||||
| Goodwill | 25.74M | 25.74M | 25.74M | ||||||||||||||||||||||
| Intangibles | 114.30M | 114.30M | 114.30M | ||||||||||||||||||||||
| Goodwill & Intangibles | 140.04M | 140.04M | 140.04M | ||||||||||||||||||||||
| Other Non-Current Assets | 0.24M | 0.14M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.46M | 0.03M | |||||||||||||
| Non-Current Assets | 0.16M | 0.21M | 0.22M | 0.23M | 0.45M | 0.21M | 1.24M | 0.99M | 0.85M | 0.71M | 0.58M | 0.44M | 0.32M | 0.20M | 0.15M | 0.02M | 0.48M | 140.41M | 140.42M | 140.37M | |||||
| Assets | 25.36M | 22.94M | 18.85M | 14.16M | 12.02M | 7.59M | 5.59M | 5.88M | 10.23M | 5.17M | 7.29M | 4.82M | 3.94M | 7.29M | 13.19M | 8.27M | 5.23M | 162.40M | 157.16M | 151.01M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 1.98M | 2.50M | 1.83M | 1.70M | 3.75M | 4.35M | 5.06M | 3.04M | 5.14M | 3.05M | 2.37M | 3.28M | 2.13M | 2.71M | 2.51M | 1.56M | 2.97M | 3.49M | 5.29M | 4.68M | |||||
| Notes Payables | 0.04M | 0.65M | |||||||||||||||||||||||
| Payables | 1.98M | 2.54M | 1.83M | 1.70M | 3.75M | 4.35M | 5.06M | 3.04M | 5.14M | 3.05M | 2.37M | 3.28M | 2.13M | 2.71M | 2.51M | 1.56M | 2.97M | 3.49M | 5.29M | 5.33M | |||||
| Accumulated Expenses | 0.03M | 0.48M | 0.07M | 0.12M | 0.13M | 0.16M | 0.21M | 0.31M | 0.22M | 0.59M | 0.20M | 0.19M | 0.12M | 0.13M | 0.00M | 0.19M | 0.22M | 0.37M | 0.25M | 0.23M | |||||
| Current Leases | 0.39M | 0.40M | 0.40M | 0.41M | 0.34M | 0.23M | 0.15M | 0.04M | |||||||||||||||||
| Current Deferred Revenue | 0.22M | 0.03M | 0.02M | 0.02M | 0.02M | 0.08M | 0.05M | 0.03M | 0.03M | 0.03M | 0.09M | 0.06M | |||||||||||||
| Total Current Liabilities | 2.20M | 2.53M | 1.85M | 1.73M | 3.77M | 4.35M | 5.45M | 3.52M | 5.60M | 3.49M | 2.71M | 3.50M | 2.28M | 2.77M | 2.51M | 1.56M | 2.97M | 3.49M | 5.38M | 5.40M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Convertible Debt | |||||||||||||||||||||||||
| Preferred Stock Liabilities | 141.54M | 143.27M | 143.38M | ||||||||||||||||||||||
| Operating Leases | 0.38M | 0.27M | 0.19M | 0.04M | |||||||||||||||||||||
| Non-Current Deferred Tax Liability | 0.23M | 0.46M | 0.46M | ||||||||||||||||||||||
| Other Non-Current Liabilities | 0.35M | 6.54M | 0.39M | 0.55M | 0.83M | 6.80M | 6.81M | 7.45M | |||||||||||||||||
| Total Non-Current Liabilities | 2.53M | 0.04M | 6.54M | 0.39M | 0.55M | 0.83M | 7.02M | 7.27M | 7.25M | ||||||||||||||||
| Total Liabilities | 2.20M | 2.53M | 1.85M | 1.73M | 3.77M | 4.35M | 5.83M | 3.79M | 5.79M | 3.53M | 2.71M | 3.50M | 2.28M | 9.31M | 2.90M | 2.12M | 3.80M | 10.52M | 12.64M | 12.65M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Total Debt | 0.04M | 0.65M | |||||||||||||||||||||||
| Common Equity | 23.16M | 20.40M | 17.00M | 12.43M | 8.24M | 3.24M | -0.24M | 2.09M | 4.44M | 1.64M | 4.58M | 1.32M | 1.65M | -2.02M | 10.29M | 6.15M | 1.43M | 10.34M | 1.25M | -27.69M | |||||
| Liabilities and Shareholders Equity | 25.36M | 22.94M | 18.85M | 14.16M | 12.02M | 7.59M | 5.59M | 5.88M | 10.23M | 5.17M | 7.29M | 4.82M | 3.94M | 7.29M | 13.19M | 8.27M | 5.23M | 162.40M | 157.16M | 151.01M | |||||
| Retained Earnings | 30.67M | 30.71M | 30.77M | 30.87M | 30.98M | 31.11M | -32.70M | 39.12M | 46.77M | 48.06M | 54.33M | 56.26M | 58.91M | -63.20M | 85.58M | 85.71M | 85.85M | 108.20M | 116.90M | -122.40M | |||||
| Preferred Shares | 121.00 | 121.00 | |||||||||||||||||||||||
| Treasury Shares | 0.00M | 0.00M | 0.00M |